A general purpose pharmacokinetic model for propofol.

Area of Science:

• Pharmacology
• Anesthesiology
• Pharmacometrics

Background:

• Pharmacokinetic (PK) models are crucial for predicting drug concentrations and guiding infusion rates in anesthesia.
• Existing propofol PK models often lack generalizability, being developed for specific patient groups or anesthetic techniques.
• This limits their accuracy under diverse patient and clinical conditions.

Purpose of the Study:

• To develop a single propofol pharmacokinetic (PK) model with robust predictive performance across a wide range of patient groups and clinical conditions.
• To address the uncertainty associated with existing models in varied populations.

Main Methods:

• Aggregated and analyzed 21 propofol datasets encompassing diverse demographics (pediatric, adult, elderly, obese).
• Estimated a 3-compartmental allometric model using NONMEM, incorporating weight, age, sex, and patient status as covariates.
• Utilized a novel predictive performance metric focused on intraoperative conditions and Akaike information criteria for model selection.

Main Results:

• The final model integrated data from 660 individuals (0.25-88 years; 5.2-160 kg) with 10,927 concentration observations.
• Covariates included weight, age, sex, and patient status (vs. healthy volunteer).
• The model demonstrated superior or comparable predictive performance to specialized models across subpopulations.

Conclusions:

• A single, generalized propofol PK model has been developed with strong predictive capabilities for diverse patient populations and clinical scenarios.
• Further prospective validation is recommended to confirm the model's clinical utility.